Tsiklomed - a drug from the group of m-holinomimetikov used in ophthalmology.

Besalol, Bekarbon, Belastezin, Anuzol, atropine sulfate, Belladonna extract taken, Betiol, Midriatsil, Buscopan, Gastrotipin, Irifrin, Gastropin, gastrotsepin, Ipravent - drugs Tsiklomeda peers (members of the same pharmacological group).  Ophthalmic drug Tsiklomed

Structure and Composition Tsiklomeda

Tsiklomed produced as a clear solution in a plastic dropper flakonchike 5 ml.

1 ml Tsiklomeda on instructions contains 0, 01 g of cyclopentolate hydrochloride and auxiliaries - 0, 0001 g of benzalkonium chloride, disodium edetate, sodium chloride, water for injection.

Pharmacological action

Cyclopentolate blocks m-cholinergic receptors, thus contributing to the voltage of the ciliary (ciliary) muscles of the eye and the simultaneous relaxation of the muscles, narrowing the pupil. Relaxation of the ciliary muscle of the eye leads to the development of paralysis of accommodation - cycloplegia. Temporary paralysis of accommodation helps to restore lost functions of the eye, under certain eye diseases, and allows to distinguish the true from the spasm of accommodation in the diagnosis of myopia.

Tsiklomed easily penetrates through the conjunctiva. Cyclopentolate pharmacological activity reaches the maximum within 20-30 minutes after a single instillation Tsiklomeda. The feedback to the Tsiklomedu states that the pupil is spread over 7-12 hours after instillation of the drug, and in some cases much longer. Residual effects of paresis of accommodation can persist for days after instillation of the drops.

Judging by the reviews, Tsiklomed has antispasmodic effect, reduces the secretion of gastric glands, saliva, sweat, bronchial glands and pancreas. The drug in therapeutic doses has a stimulating effect on the nervous system (manifested after 30-60 minutes after instillation of the preparation), contributing to elevated intraocular pressure and reduced vagal tone, which leads to the development of tachycardia and a slight increase in blood pressure.

Indications Tsiklomeda

According to the instructions, or analogues Tsiklomed Tsiklomeda used in determining refraction at ophthalmoscopy; in the preoperative (mydriasis before cataract surgery). In addition, Tsiklomed used in treatment of scleritis, episcleritis, iridocyclitis, keratitis, uveitis - inflammatory diseases of the eye (anterior section).

Tsiklomed - Instructions for use

According to the instructions Tsiklomed used topically, digging into conjunctival cavity 1-2 drops of the drug.

When inflammation is instilled in the eye one drop of the drug three times a day. In some cases, the dosage may be increased Tsiklomeda - 1 drop every three to four hours. During the instillation solution in the conjunctival cavity should press the lower lacrimal point to avoid getting Tsiklomeda the nasopharynx.

For the procedure of research fundus sufficiently bury one drop solution Tsiklomed one to three times per day.  Eye drops Tsiklomed

To investigate refraction adolescents and children administered one drop of the drug two or three times a day.


  • hypersensitivity to any component of the drug;
  • glaucoma.

Be wary appoint Tsiklomed pregnancy, intestinal obstruction, prostatic hyperplasia, elderly patients and children up to three years.

Side effects Tsiklomeda

Judging by the reviews of Tsiklomede Tsiklomeda and analogues, long-term consequences of the use of drops may be as follows: the emergence of dizziness, nausea, drowsiness, headache, dry mouth, conjunctival hyperemia, discomfort upon instillation of the solution, as well as decreased visual acuity of a temporary nature.

Tsiklomed - the effects of overdose

Judging by the reviews to Tsiklomedu, an overdose of the drug may experience the following symptoms: dryness of mucous membranes and skin, nervous and mental disorders (disorientation, fatigue, speech disorders, emotional disorders).

In applying the diversion of the drug Tsiklomed consequences may be irreversible (depression of respiratory function up to coma or death).

Drug interaction Tsiklomeda

Metazon and other sympathomimetics enhance the therapeutic effect of the drug. Pilocarpine and other m-holinomimetiki weaken the effect Tsiklomeda.

One-time use Tsiklomeda and other m-anticholinergics may increase its side effects.


The therapeutic effect of the drops diminished in patients with dark pigment of the iris.

Elderly patients when used Tsiklomeda should carefully monitor the performance of intraocular pressure.

Patients with hypersensitivity to atropine do not give cross-allergy to the drug Tsiklomed.

Children with persistent or semiproof spasm of accommodation for the course is preferable to use cycloplegic instillation of atropine sulfate - analogue Tsiklomeda.

storage conditions

Store in a dry, sheltered from the sun, at a temperature of not less than 25 ° C.

Shelf life - 2 years.